ATC Group: A11GA01 Ascorbic acid (vit C)

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A11GA01 in the ATC hierarchy

Level Code Title
1 A Alimentary tract and metabolism
2 A11 Vitamins
3 A11G Ascorbic acid (Vitamin C), incl. combinations
4 A11GA Ascorbic acid (vitamin C), plain
5 A11GA01 Ascorbic acid (vit C)

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 0.2 g
PAREN - Parenteral 0.2 g

Active ingredients in A11GA01

Active Ingredient Description
Vitamin C

Ascorbic acid, coupled with dehydroascorbic acid to which it is reversibly oxidised, has a variety of functions in cellular oxidation processes. Ascorbic acid is required in several important hydroxylations, including the conversion of proline to hydroxyproline and appears to have an important role in metal ion metabolism, including the gastrointestinal absorption of iron and its transport between plasma and storage organs.

Related product monographs

Title Information Source Document Type  
ASCOR Solution for injection FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicines in this ATC group

United States (US)

Austria (AT)

Estonia (EE)

Finland (FI)

Hong Kong (HK)

Lithuania (LT)

Malta (MT)

Mexico (MX)

New Zealand (NZ)

Tunisia (TN)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.